About the Authors
- Praveen Papareddy, Victoria Rydengård, Mukesh Pasupuleti, Anna Chalupka, Artur Schmidtchen
- Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden
- Björn Walse
- SARomics AB, Lund, Sweden
- Matthias Mörgelin
- Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden
- Anna Chalupka
- Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland
- Martin Malmsten
- Department of Pharmacy, Uppsala University, Biomedical Center, Uppsala, Sweden
Drs. Schmidtchen and Malmsten have shares in DermaGen AB and XImmune AB, companies involved in the therapeutic development of peptides for topical and systemic use, respectively.
Conceived and designed the experiments: P. Papareddy, M. Malmsten, A. Schmidtchen. Performed the experiments: P. Papareddy, V. Rydengård, M. Pasupuleti, M. Mörgelin, A. Chalupka, M. Malmsten. Analyzed the data: P. Papareddy, V. Rydengård, B. Walse, M. Mörgelin, M. Malmsten, A. Schmidtchen. Contributed reagents/materials/analysis tools: A. Schmidtchen. Wrote the paper: A. Schmidtchen.